Biomerica Inc.
1533 Monrovia Avenue
Newport Beach
California
92663
United States
Tel: 714-645-2111-or-800-854-3002
Fax: 714-722-6674
Website: http://www.biomerica.com/
Email: bmra@biomerica.com
139 articles about Biomerica Inc.
-
Biomerica Announces Second Quarter Financial Results
1/15/2015
-
Biomerica Has Filed A First Set Of Patent Applications With The USPTO For A New Test To Aid In The Treatment Of A Gastrointestinal Disorder
1/12/2015
-
Biomerica Reports First Quarter Results
10/16/2014
-
Biomerica Announces Year End Results
9/4/2014
-
Biomerica To Supply Its Colorectal Screening Point Of Care Test To Multinational Pharmaceutical Company With Over $40 Billion In Sales
8/11/2014
-
Biomerica Announces Two New China CFDA Approvals And A New Distribution Channel In China
6/4/2014
-
Biomerica Announces Third Quarter Financial Results
4/16/2014
-
Biomerica Announces Completion Of Strategic Investment
1/23/2014
-
Biomerica Announces Second Quarter Financial Results
1/15/2014
-
Biomerica To Supply Two Of Its Point Of Care Products To Multinational Pharmaceutical Company With Over $40 Billion In Sales
1/14/2014
-
Biomerica Announces Year End Results -- Sales Up Over 6%
8/30/2013
-
Biomerica Receives Approval to Market Its H. Pylori and PTH Products in Mexico and Appoints New Distributor in Mexico
8/7/2013
-
Biomerica Announces Third Quarter Financial Results
4/16/2013
-
Biomerica Announces Second Quarter Financial Results
1/15/2013
-
Biomerica Reports First Quarter Revenue Growth of 20.9%, Net Income Up Over 147%
10/15/2012
-
Biomerica Announces Year End Results: Sales Up Over 24%; Net Income $0.08 Per Share Versus $0.02 Per Share
8/30/2012
-
Biomerica Announces Third Quarter Financial Results
4/17/2012
-
Biomerica Introduces Two New E. Coli Tests: Verotoxin and E. Coli 0157
3/6/2012
-
Biomerica Launches New Patented Test to Identify Individuals at Risk of Developing Severe Side Effects From Thiopurine Drugs
1/31/2012
-
Biomerica Announces Second Quarter Financial Results
1/18/2012